CBLL - Multiplikator forward rega marang pendapatan CeriBell EEG
CeriBell, Inc. (CBLL) management is effectively scaling its fleet of AI systems across US hospitals. The forward price-to-sales valuation trend on the precise GURU.Markets chart shows that the current parameter is 9.40. Growth is driven by the implementation of EEG monitoring in intensive care units and the expansion of insurance coverage, while valuation potential is supported by the intensive development of breakthrough rapid seizure diagnostic algorithms.
Ringkesan rincian data analitis CeriBell EEG (CBLL)
- rega pasar lan target rega analis:
- statistik kapitalisasi pasar:
- rincian valuasi buku bisnis:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal CeriBell, Inc.|CBLL - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas CeriBell, Inc.|CBLL - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku CeriBell EEG|CBLL - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan CeriBell|Likuiditas cepet ceribell.com
- rincian asil keuangan lan kelipatan valuasi:
CBLL - Bathi resik perusahaan|Bathi sing dikarepake CeriBell, Inc.|CBLL - Rasio rega marang bathi|Rega marang bathi mangsa ngarep CeriBell Corp|CBLL - Rasio P/E diaturake wutah|Pangali EV/EBITDA CeriBell EEG|CBLL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan CeriBell|CBLL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ceribell.com|CBLL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CeriBell, Inc.
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:CeriBell CBLL
Rising sales of CeriBell, Inc. (CBLL) disposable sensors across hospital networks are creating a steady cash flow that directly impacts the business's market value. The ratio of current capitalization to projected revenue, illustrated via the forward P/S chart, allows for the valuation of future earnings without the delays of quarterly reporting. This metric's price action helps investors balance potential returns against the risks of asset overvaluation.
Pesaing CeriBell, Inc. (CBLL)
Rasio rega marang prakiraan pendapatan Biogen BIIB|Neurocrine - Rasio rega marang prakiraan pendapatan|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Corp)|ACAD: Multiplikator Forward P/S|XENE - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|Kapitalisasi marang prakiraan pendapatan SUPN (Supernus Pharmaceuticals, Inc.)|Multiplikator Forward P/S CPRX|Multiplikator forward rega marang pendapatan Denali Corp DNLI|Harmony Biosciences - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake biohavenpharma.com (BHVN)|Amylyx Pharmaceuticals, Inc. - Multiplikator Forward P/S|Trevi Therapeutics Inc (TRVI) - Multiplikator forward rega marang pendapatan|PRAX: Multiplikator Forward P/S|AVXL (Anavex Life Sciences Corp) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Prothena Biosciences|Rasio rega marang prakiraan pendapatan ALEC|Rasio rega marang prakiraan pendapatan Annexon (ANNX)|Rasio rega marang prakiraan pendapatan OMER (omeros.com)|Rasio rega marang prakiraan pendapatan Neurogene Corp NGNE|ACIU: Kapitalisasi marang prakiraan pendapatan|Voyager Therapeutics - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep neumoratx.com|SCLX (Scilex) - Multiplikator forward rega marang pendapatan|Tevogen Bio Holdings Inc. (TVGN) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Alpha Cognition Inc|CGTX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Inhibikase Therapeutics (IKT)|SAVA - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S ASRT (Assertio)|COYA - Multiplikator forward rega marang pendapatan|VistaGen Therapeutics Inc - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ovid Therapeutics Inc.|Acumen Pharmaceuticals (ABOS) - Rasio rega marang prakiraan pendapatan|cervomed.com - Rega forward marang dodolan|ATHE (Alterity Therapeutics Ltd.) - Multiplikator Forward P/S|Clene Nanomedicine (CLNN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PEPG|Rasio rega marang prakiraan pendapatan JUNS (Jupiter Neurosciences, Inc.)|Multiplikator Forward P/S RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GRCE - Rasio rega marang prakiraan pendapatan|AIFF: Rasio rega marang prakiraan pendapatan|anewmeds.com (KLTO) - Rasio rega marang prakiraan pendapatan|NRSN (NeuroSense Therapeutics Ltd.) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan RVPH|MTVA: Rega forward marang dodolan|Multiplikator Forward P/S NRXS|Rasio kapitalisasi marang dodolan sing dikarepake heliusmedical.com|Rasio rega marang prakiraan pendapatan Passage Bio PASG|NEUP: Kapitalisasi marang prakiraan pendapatan|Minerva Neurosciences - Multiplikator Forward P/S|athira.com (ATHA) - Multiplikator forward rega marang pendapatan|ADXN (Addex Therapeutics Ltd) - Multiplikator forward rega marang pendapatan|ALZN - Rasio kapitalisasi marang dodolan sing dikarepake|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Protagenic (PTIX)|Multiplikator Forward P/S KTTA|Rasio rega marang prakiraan pendapatan CRGT (cortigent.com)|Rasio rega marang prakiraan pendapatan Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|CARA - Rasio rega marang prakiraan pendapatan|CHRO: Rasio rega marang prakiraan pendapatan|eliemtx.com (ELYM) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ITCI|LBPH (Longboard Pharmaceuticals, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Marinus Pharmaceuticals Inc MRNS|Multiplikator forward rega marang pendapatan NKGN (NKGen)|Multiplikator Forward P/S NeuroBo Pharma (NRBO)|Rasio rega marang prakiraan pendapatan Sage Therapeutics, Inc. SAGE|Rega forward marang dodolan SNPX|TRVN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Vigil Neuroscience|WENA: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Cerevel Corp
